EXSCEL—once-weekly exenatide reduces medical resource utilization in patients with type 2 diabetes mellitus
Huvudupphovsmän: | , , , , , , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Publicerad: |
American Diabetes Association
2018
|